Short description
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Description
Roivant Sciences is a biopharmaceutical company focused on completing the development of promising late-stage drug candidates.
Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. Roivant does this by building Vants - nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying the technology. In addition to its biopharmaceutical subsidiaries, Roivant also builds technology-focused Vants focused on improving the process of developing and commercializing medicines.
Last funding
Cannot Access
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
New York, New York, United States, North America
Founded on
May 1, 2014
Exited on
October 1, 2021
Went public on
October 1, 2021
Stock symbol
ROIV
Non-profit?
No
Acquired?
No
Employees count
501-1000
Revenue range
$56378 - 90123
Sign in for full access
Investors
No Way, No Way, Uh Ohhhh, Blurry Noaccess, Blurry Noaccess, Cannot Access, No Way, Noaccess, Cannot Access, Uh Ohhhh, Noaccess, Blurry Noaccess, Absolutely Noaccess, Noaccess, Noaccessforu
Sign in for full access
Founders
Vivek Ramaswamy
Funding rounds count
7
Portfolio organisations count
No Way, Noaccess
Sign in for full access
Lead investments count
3
Exits count
Blurry Noaccess, No Way
Sign in for full access
IPO exits count
2